Qingdao Novelbeam Technology688677.SHValuation Analysis

As of Oct 19, 2026, Qingdao Novelbeam Technology (688677.SH) trades at a P/E of 42.70x, P/B of 5.50x, P/S of 11.50x, and a dividend yield of 0.96%.
Longitudinal percentile comparison: P/E sits at the 45th percentile over the trailing 10Y window (vs. 68th percentile over 3Y); P/B sits at the 49th percentile over the trailing 10Y window (vs. 76th percentile over 3Y); P/S sits at the 34th percentile over the trailing 10Y window (vs. 58th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 55th percentile within its industry and the 56th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 1.68%, ranking at the 63rd percentile over the trailing 20Y window.
Cross-checking P/E against P/B, the two percentiles sit within 3.9 points of each other — a consistent signal from both angles. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Of the 1.68% total shareholder yield, 0.96% is paid out as dividends and roughly 0.71% is implied to come from buybacks — both channels are meaningfully in play. Qingdao Novelbeam Technology operates in the Medicine sector. Data refreshes weekly and is for reference only, not investment advice.